p53-oligomer inhibitors (Treventis)

N/A

Report date: 2025/01/26 17:25:34
NME

Base Information

Drug Namep53-oligomer inhibitors (Treventis)
Drug Alias Nameneoplasms therapeutic (Treventis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTreventis Corp
China Registration ClassN/A

Develop Information

Active CompaniesTreventis Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A